Eli Lilly Shares Surge Over 9% After Strong Earnings Report

FXOpen

As the chart of Eli Lilly's (LLY) share price shows today, yesterday's trading closed at a level more than 9% higher than Wednesday's closing price. The main driver of this growth was a strong Q2 report:

→ Earnings per share: actual = $3.92, expected = $2.74;
→ Gross sales: actual = $11.3 billion, expected = $9.99 billion.

Market participants reacted positively not only to the fact that the American pharmaceutical company's actual results significantly exceeded forecasts but also to Eli Lilly's rising expectations for the second half of the year, driven by demand for its diabetes treatment Mounjaro and weight loss drug Zepbound.

Technical analysis of the Eli Lilly (LLY) stock chart shows that:
→ The price action is forming an upward channel in 2024 (shown in blue);
→ After a rebound, the median line of this channel was breached (as indicated by the arrow);
→ As could be expected, this line acted as resistance – as indicated by the high of yesterday's candlestick.

What is the forecast for Eli Lilly (LLY) shares?

Wall Street analysts surveyed by TipRanks remain positive – none of them recommend selling shares of the company, which has the largest market cap in the healthcare sector at over $800 billion. On average, they forecast that LLY shares will reach $955 within 12 months.

This suggests that the current upward channel may remain relevant. However, it’s possible that:
→ The lower boundary will continue to act as support;
→ The boundaries of the bullish gap formed at yesterday's opening may also provide support. A similar action can be seen on the chart – after a wide bullish gap (also formed following a strong report) on 30 April, LLY shares found support near the lower boundary of that gap around $740.

Buy and sell stocks of the world's biggest publicly-listed companies with CFDs on FXOpen’s trading platform. Open your FXOpen account now or learn more about trading share CFDs with FXOpen.

This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.

Stay ahead of the market!

Subscribe now to our mailing list and receive the latest market news and insights delivered directly to your inbox.

forex

Share CFD Trading with FXOpen

Share CFD Trading with FXOpen

Experience ECN technology for deep liquidity and light-speed trade execution

  • Trade with tight spreads
  • Take advantage of low commissions
  • Choose from 4 trading platforms: MT4, MT5, TradingView, or TickTrader
Learn more

Latest articles

Commodities

Crude Oil Price Hits New 2025 Low

As shown on the XBR/USD chart, the price of Brent crude oil dropped to $73.92 yesterday:
→ this marks a new low for 2025;
→ the decline since 15 January exceeds 9%.

Bearish sentiment is being driven by Trump's policies.

Shares

Ford (F) Share Price Drops to a 4-Year Low

As shown by the Ford (F) share price chart today, the price has fallen to $9.25 – its lowest level since early 2021.

This drop occurred following the publication of the quarterly earnings report on 5 February:

→ Earnings per share:

Forex Analysis

Yen and Euro Test Strategic Levels

The downward correction of the US currency, which began after the postponement of the tariffs announced by Trump, continues to gain momentum. The EUR/USD currency pair is trying to consolidate above 1.0400, sellers of USD/JPY have managed

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 60% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.